Hiv-1 Infection
- All
- News
-
Forgotten Antibody May Keep Away HIV Infections: Researchers
Scientists have discovered a promising class of forgotten antibodies which may offer protection against HIV-1 virus.
-
US Regulator Approves Gilead Sciences' HIV Drug Cocktail
Gilead Sciences Inc said the US Food and Drug Administration had approved its HIV drug cocktail, Genvoya, to treat patients aged 12 and above.
-
Scientists Find Potential New HIV Therapy
Scientists have discovered a way to block replication of the most common form of HIV at a key moment when the infection is just starting to develop.
-
Heart abnormalities in children of HIV positive mothers
Infants born to women infected with HIV-1 have a significantly worse cardiac function than other infants, suggesting that the uterine environment has an important role in the development of heart abnormalities after birth.
-
Forgotten Antibody May Keep Away HIV Infections: Researchers
Scientists have discovered a promising class of forgotten antibodies which may offer protection against HIV-1 virus.
-
US Regulator Approves Gilead Sciences' HIV Drug Cocktail
Gilead Sciences Inc said the US Food and Drug Administration had approved its HIV drug cocktail, Genvoya, to treat patients aged 12 and above.
-
Scientists Find Potential New HIV Therapy
Scientists have discovered a way to block replication of the most common form of HIV at a key moment when the infection is just starting to develop.
-
Heart abnormalities in children of HIV positive mothers
Infants born to women infected with HIV-1 have a significantly worse cardiac function than other infants, suggesting that the uterine environment has an important role in the development of heart abnormalities after birth.
